# CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-276-effectiveness-of-anthelmintics-specific-recommendations-for-products-proposed-for-the-prevention-of-heartworm-disease-in-dogs/6428bf8e-1efb-4173-8319-d9cf1d953630 > FDA guidance document: CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs. Issue date: June 26, 2024. Get complete insights and analysis. --- ## Details - Title: CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs - Communication Type: Guidance Document - Product Type: veterinary - Office Name: Center for Veterinary Medicine - Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4 - Issue Date: 2024-06-26 - Comment Close Date: 2023-05-01 - Last Changed: 2024-06-25 - Docket Number: FDA-2022-D-2899 ## Related Documents - [CVM GFI #253 Current Good Manufacturing Practice for Animal Cells, Tissues, and Cell- and Tissue-Based Products](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-253-current-good-manufacturing-practice-for-animal-cells-tissues-and-cell-and-tissue-based-products/9f83a1f8-185e-425f-bfdc-882e095586c3) - [CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-278-human-user-safety-in-new-and-abbreviated-new-animal-drug-applications/0a0c64dc-c687-44fe-b47c-72ab2723a713) - [CVM GFI #254 Donor Eligibility for Animal Cells, Tissues, and Cell- and Tissue-Based Products](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-254-donor-eligibility-for-animal-cells-tissues-and-cell-and-tissue-based-products/d5eb6da2-94b5-41a2-a968-ac68b7a3a918)